HomeSPRY • NASDAQ
add
ARS Pharmaceuticals Inc
Previous close
$14.05
Day range
$13.91 - $14.60
Year range
$7.55 - $18.51
Market cap
1.42B USD
Avg Volume
2.11M
P/E ratio
185.25
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 86.58M | — |
Operating expense | 35.49M | 420.26% |
Net income | 49.93M | 796.62% |
Net profit margin | 57.67 | — |
Earnings per share | 0.51 | 828.57% |
EBITDA | 47.23M | 562.37% |
Effective tax rate | 0.57% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 314.02M | 37.51% |
Total assets | 351.15M | 50.59% |
Total liabilities | 94.36M | 3,786.12% |
Total equity | 256.80M | — |
Shares outstanding | 98.12M | — |
Price to book | 5.36 | — |
Return on assets | 41.49% | — |
Return on capital | 44.75% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 49.93M | 796.62% |
Cash from operations | 42.00M | 341.33% |
Cash from investing | -101.76M | -490.80% |
Cash from financing | 70.92M | 3,828.86% |
Net change in cash | 11.16M | 6.91% |
Free cash flow | 16.57M | 221.77% |
About
Founded
2015
Website
Employees
158
